Skip to main content

Table 2 Distribution of marker values between patient and control groups

From: Bone alkaline phosphatase as a surrogate marker of bone metastasis in gastric cancer patients

Mean ± SD

Patient (n = 29)

Control (n = 29)

P

Osteocalcin (ng/mL)

25.55 ± 4.15

26.42 ± 3.33

0.881

Bone ALP (μg/L)

57.32 ± 46.83

34.57 ± 21.57

0.037

CTx (ng/mL)

1.19 ± 1.73

0.74 ± 0.32

0.193

25 (OH)D(ng/mL)

12.72 ± 7.44

12.06 ± 5.54

0.717

PTH (pg/mL)

42.97 ± 14.70

54.44 ± 57.26

0.350

  1. Analyzed by paired t-test
  2. SD standard deviation, ALP alkaline phosphatase, CTx serum collagen type 1 cross-linked C-telopeptide, PTH parathyroid hormone
  3. Significant P-values in bold letters
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us